Related Experiment Video
Updated: Mar 23, 2026
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Tania Løve Aaes1, Agnieszka Kaczmarek1, Tinneke Delvaeye2
1Molecular Signaling and Cell Death Unit, Inflammation Research Center, VIB, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Cancer Research Institute Ghent (CRIG), Ghent University, 9052 Ghent, Belgium.
Abstract:
Successful immunogenic apoptosis in experimental cancer therapy depends on the induction of strong host anti-tumor responses. Given that tumors are often resistant to apoptosis, it is important to identify alternative molecular mechanisms that elicit immunogenic cell death. We have developed a genetic model in which direct dimerization of FADD combined with inducible expression of RIPK3 promotes necroptosis. We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic T cells, and the production of IFN-γ in response to tumor antigen stimulation. Using both FADD-dependent and FADD-independent RIPK3 induction systems, we demonstrate the efficient vaccination potential of immunogenic necroptotic cells. Our study broadens the current concept of immunogenic cell death and opens doors for the development of new strategies in cancer therapy.
Insights
Necroptosis, a form of programmed cell death, can be induced in cancer cells to trigger anti-tumor immune responses. This study shows necroptotic cells can be used for effective cancer vaccination strategies.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Immunogenic apoptosis is crucial for cancer therapy, but tumors often resist apoptosis.
- Alternative cell death pathways are needed to induce anti-tumor immunity.
Purpose of the Study:
- To investigate necroptosis as an alternative to apoptosis for inducing immunogenic cell death.
- To develop a genetic model for controlled necroptosis induction in cancer cells.
Main Methods:
- Developed a genetic model inducing necroptosis via FADD dimerization and RIPK3 expression.
- Analyzed the release of damage-associated molecular patterns (DAMPs) from necroptotic cells.
- Assessed dendritic cell maturation and cytotoxic T cell cross-priming.
- Evaluated the vaccination potential of necroptotic cells in vivo.
Main Results:
- Necroptotic cancer cells release DAMPs, promoting dendritic cell maturation.
- Necroptosis facilitates cross-priming of cytotoxic T cells and IFN-γ production.
- Both FADD-dependent and FADD-independent RIPK3 induction systems showed effective vaccination potential.
- Immunogenic necroptotic cells demonstrated significant anti-tumor vaccination efficacy.
Conclusions:
- Necroptosis is a viable alternative to apoptosis for inducing immunogenic cell death in cancer therapy.
- Necroptotic cells can serve as effective cancer vaccines by stimulating anti-tumor immune responses.
- This research expands the understanding of immunogenic cell death and offers new therapeutic avenues for cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:51Vaccinations
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:21Vaccines